Does factor VIIa binding to endothelial cell protein C receptor protect vascular barrier integrity in vivo?
This is the first study to demonstrate that FVIIa binding to EPCR leads to a barrier protective effect in vivo. This finding may have clinical relevance, as it indicates additional advantages of using FVIIa in treating hemophilic patients.
Yellow filters improve response times for younger adults for visual tasks relevant to driving.